| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT06941844 A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) |
Trial sites reduced: 25 -> 22 locations |
| 2026-07-30 | NCT07592689 A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) |
Trial sites expanded: 27 -> 32 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07592689 | A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) | Major Depressive Disorder | Recruiting |
| NCT06741228 | A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) | Generalized Anxiety Disorder | Active, Not Recruiting |
| NCT06809595 | A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) | Generalized Anxiety Disorder | Active, Not Recruiting |
| NCT06941844 | A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) | Major Depressive Disorder | Active, Not Recruiting |
| Phase 2 | |||
| NCT07303907 | A Phase 2A Trial of DT402 for Autism Spectrum Disorder | Autism Spectrum Disorder | Recruiting |